1. Home
  2. KORE vs LEXX Comparison

KORE vs LEXX Comparison

Compare KORE & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • LEXX
  • Stock Information
  • Founded
  • KORE 2003
  • LEXX 2004
  • Country
  • KORE United States
  • LEXX Canada
  • Employees
  • KORE N/A
  • LEXX 7
  • Industry
  • KORE Telecommunications Equipment
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • KORE Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • KORE 24.7M
  • LEXX 38.9M
  • IPO Year
  • KORE N/A
  • LEXX N/A
  • Fundamental
  • Price
  • KORE $1.30
  • LEXX $2.23
  • Analyst Decision
  • KORE Buy
  • LEXX Strong Buy
  • Analyst Count
  • KORE 2
  • LEXX 2
  • Target Price
  • KORE $10.00
  • LEXX $11.00
  • AVG Volume (30 Days)
  • KORE 71.7K
  • LEXX 202.4K
  • Earning Date
  • KORE 11-19-2024
  • LEXX 01-10-2025
  • Dividend Yield
  • KORE N/A
  • LEXX N/A
  • EPS Growth
  • KORE N/A
  • LEXX N/A
  • EPS
  • KORE N/A
  • LEXX N/A
  • Revenue
  • KORE $285,229,000.00
  • LEXX $464,278.00
  • Revenue This Year
  • KORE $3.89
  • LEXX $20.39
  • Revenue Next Year
  • KORE $5.69
  • LEXX $113.25
  • P/E Ratio
  • KORE N/A
  • LEXX N/A
  • Revenue Growth
  • KORE 7.01
  • LEXX 105.24
  • 52 Week Low
  • KORE $1.10
  • LEXX $1.20
  • 52 Week High
  • KORE $6.45
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • KORE 32.03
  • LEXX 47.23
  • Support Level
  • KORE $1.10
  • LEXX $2.00
  • Resistance Level
  • KORE $1.25
  • LEXX $2.54
  • Average True Range (ATR)
  • KORE 0.15
  • LEXX 0.24
  • MACD
  • KORE -0.00
  • LEXX -0.00
  • Stochastic Oscillator
  • KORE 27.08
  • LEXX 27.06

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: